J&J makes takeover approach for Swiss drugmaker Actelion: Report

U.S. health care company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover, Bloomberg reported on Thursday.

from Mergers and Acquisitions http://ift.tt/2fxoekn